Arbidol hydrochloride compatibility study with starchy excipients using DSC, FTIR, TGA-FTIR, and PXRD methods
The broad spectrum of antiviral activity and relatively low toxicity of arbidol hydrochloride have made it an interesting subject of research. Additionally, there is no information available regarding its formulation with various excipients. Another drawback is its hydrophobic nature, which contribu...
Saved in:
Published in | Journal of thermal analysis and calorimetry Vol. 150; no. 6; pp. 4151 - 4164 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Nature B.V
01.03.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 1388-6150 1588-2926 |
DOI | 10.1007/s10973-025-14056-4 |
Cover
Loading…
Abstract | The broad spectrum of antiviral activity and relatively low toxicity of arbidol hydrochloride have made it an interesting subject of research. Additionally, there is no information available regarding its formulation with various excipients. Another drawback is its hydrophobic nature, which contributes to lower bioavailability in specific drug forms. Therefore, it is necessary to test its mixtures with excipients to identify those that can enhance its solubility in water. For this reason, tests of compatibility/incompatibility of mixtures of arbidol hydrochloride with starchy excipients such as dextrin, polydextrose, and hydroxypropyl starch were carried out using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), thermogravimetry coupled with Fourier transform infrared spectroscopy (TGA-FTIR), and powder X-ray diffraction (PXRD). Additionally, phase diagrams were developed for arbidol hydrochloride mixtures with starchy polymers, which enabled prediction of the solubility of this active pharmaceutical ingredient (API) in polymers and the mutual miscibility of the ingredients. The study concluded that arbidol hydrochloride may be compatible with dextrin. |
---|---|
AbstractList | The broad spectrum of antiviral activity and relatively low toxicity of arbidol hydrochloride have made it an interesting subject of research. Additionally, there is no information available regarding its formulation with various excipients. Another drawback is its hydrophobic nature, which contributes to lower bioavailability in specific drug forms. Therefore, it is necessary to test its mixtures with excipients to identify those that can enhance its solubility in water. For this reason, tests of compatibility/incompatibility of mixtures of arbidol hydrochloride with starchy excipients such as dextrin, polydextrose, and hydroxypropyl starch were carried out using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), thermogravimetry coupled with Fourier transform infrared spectroscopy (TGA-FTIR), and powder X-ray diffraction (PXRD). Additionally, phase diagrams were developed for arbidol hydrochloride mixtures with starchy polymers, which enabled prediction of the solubility of this active pharmaceutical ingredient (API) in polymers and the mutual miscibility of the ingredients. The study concluded that arbidol hydrochloride may be compatible with dextrin. |
Author | Bartyzel, Agata Leyk, Edyta Rojek, Barbara Plenis, Alina |
Author_xml | – sequence: 1 givenname: Barbara orcidid: 0000-0002-4815-9630 surname: Rojek fullname: Rojek, Barbara – sequence: 2 givenname: Agata surname: Bartyzel fullname: Bartyzel, Agata – sequence: 3 givenname: Edyta surname: Leyk fullname: Leyk, Edyta – sequence: 4 givenname: Alina surname: Plenis fullname: Plenis, Alina |
BookMark | eNotkE9LwzAchoNMcE6_gKeA11V_-dO0PY7NzcFAmT14C22S2oy2mUmH9ttbnaf3Oby8LzzXaNK5ziB0R-CBACSPgUCWsAhoHBEOsYj4BZqSOE0jmlExGZmNLEgMV-g6hAMAZBmQKWoXvrTaNbgetHeqbpy32mDl2mPR29I2th9w6E96wF-2r0csvKoHbL6VPVrT9QGfgu0-8OptOcfrfLuf43yziM5UdBq_vu9XuDV97XS4QZdV0QRz-58zlK-f8uVztHvZbJeLXaQoFX3EOOdQaVKC0LHmpVA0MVybUgmuQKe8EgUHnhoBIsvKUmTEqJKxgmYsAcFm6P48e_Tu82RCLw_u5LvxUTJKEwZMEBhb9NxS3oXgTSWP3raFHyQB-WtVnq3K0ar8syo5-wE-QWtL |
Cites_doi | 10.1016/j.molliq.2021.118300 10.1002/jps.23992 10.1016/j.ejpb.2012.12.018 10.3389/fphar.2019.00014 10.3390/v14061226 10.1016/j.ajps.2014.07.001 10.1016/j.carbpol.2016.09.094 10.1007/s10765-008-0415-z 10.3390/v13081665 10.1080/03639045.2016.1225755 10.1016/S0144-8617(00)00245-9 10.1524/zkri.2011.1399 10.1016/S0378-5173(01)00801-8 10.3390/v10040184 10.1016/j.molliq.2024.124074 10.1007/s11095-014-1500-6 10.1021/acsomega.1c04866 10.1016/j.ejpb.2016.06.024 10.1016/j.ijpharm.2010.04.037 10.3390/molecules29010264 10.1016/j.carbpol.2022.119680 10.3390/ph14050411 10.1016/j.antiviral.2008.10.009 10.1016/j.ijbiomac.2016.02.030 10.1021/acs.biomac.8b01150 10.3390/pharmaceutics15010226 10.1016/B978-0-444-53242-8.00006-0 10.1016/S0144-8617(02)00259-X |
ContentType | Journal Article |
Copyright | Akadémiai Kiadó Zrt 2025. |
Copyright_xml | – notice: Akadémiai Kiadó Zrt 2025. |
DBID | AAYXX CITATION |
DOI | 10.1007/s10973-025-14056-4 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1588-2926 |
EndPage | 4164 |
ExternalDocumentID | 10_1007_s10973_025_14056_4 |
GroupedDBID | -Y2 .86 .VR 06C 06D 0R~ 0VY 1N0 2.D 203 29L 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAIKT AAJBT AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYXX AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDBF ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACSTC ACUHS ACZOJ ADHIR ADHKG ADKNI ADKPE ADMLS ADPHR ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHPBZ AHSBF AHWEU AHYZX AI. AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ATHPR AXYYD AYFIA AYJHY AZFZN B-. B0M BA0 BDATZ BGNMA BSONS CAG CITATION COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EAD EAP EBLON EBS EIOEI EJD EMK EPL ESBYG ESX F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMJXF HQYDN HRMNR HVGLF HZ~ I-F IAO IHE IJ- IKXTQ ISR ITC ITM IWAJR IXC IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV LAK LLZTM M4Y MA- MET MKB N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P9N PF0 PT4 PT5 QOK QOR QOS R89 R9I RKA RNI RNS ROL RPX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3B SAP SCG SCLPG SCM SDH SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW STPWE SZN T13 T16 TEORI TSG TSK TSV TUC TUS U2A UG4 UOJIU UTJUX UZXMN VC2 VFIZW VH1 W23 W48 W4F WJK WK8 YLTOR Z45 ZE2 ZMTXR ~02 ~8M ABRTQ |
ID | FETCH-LOGICAL-c226t-34440fd1b06d5d4b6c27e4debc64c0d84f6a4048e60699bb691ecb33a2937063 |
ISSN | 1388-6150 |
IngestDate | Sat Aug 23 12:57:21 EDT 2025 Thu Jul 10 10:10:19 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c226t-34440fd1b06d5d4b6c27e4debc64c0d84f6a4048e60699bb691ecb33a2937063 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ORCID | 0000-0002-4815-9630 |
PQID | 3227303610 |
PQPubID | 2043843 |
PageCount | 14 |
ParticipantIDs | proquest_journals_3227303610 crossref_primary_10_1007_s10973_025_14056_4 |
PublicationCentury | 2000 |
PublicationDate | 2025-03-01 |
PublicationDateYYYYMMDD | 2025-03-01 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht |
PublicationTitle | Journal of thermal analysis and calorimetry |
PublicationYear | 2025 |
Publisher | Springer Nature B.V |
Publisher_xml | – name: Springer Nature B.V |
References | E Stefanis (14056_CR20) 2008; 29 KV Belov (14056_CR6) 2024; 397 B Rojek (14056_CR8) 2024; 29 A Forster (14056_CR23) 2001; 226 MK Anwer (14056_CR27) 2021; 14 VA Eventova (14056_CR5) 2023; 15 DC Novo (14056_CR14) 2022; 292 X Qian (14056_CR4) 2022; 14 N Masina (14056_CR11) 2017; 157 X Li (14056_CR28) 2017; 43 IA Leneva (14056_CR1) 2009; 81 E Assaad (14056_CR12) 2010; 394 Ch Gao (14056_CR15) 2019; 20 J Djuris (14056_CR21) 2013; 84 S Baghel (14056_CR17) 2016; 107 M Maniruzzaman (14056_CR22) 2014; 103 SHM Najafi (14056_CR13) 2016; 87 RM Silverstein (14056_CR29) 2005 AS Narang (14056_CR7) 2009 I Leneva (14056_CR2) 2021; 13 AB Salim (14056_CR10) 2020; 10 RC Rowe (14056_CR9) 2009 M Černá (14056_CR30) 2003; 51 M Kačuráková (14056_CR31) 2001; 44 K Ishino (14056_CR25) 2021; 6 V Chernyshev (14056_CR26) 2011; 226 J Haviernik (14056_CR3) 2018; 10 B Tian (14056_CR16) 2015; 32 L Wang (14056_CR24) 2015; 10 E Leyk (14056_CR18) 2019; 10 Ch Zhang (14056_CR19) 2022; 346 |
References_xml | – volume: 346 year: 2022 ident: 14056_CR19 publication-title: J Mol Liq doi: 10.1016/j.molliq.2021.118300 – volume-title: Spectrometric identification of organic compounds year: 2005 ident: 14056_CR29 – volume: 103 start-page: 1819 year: 2014 ident: 14056_CR22 publication-title: J Pharm Sci doi: 10.1002/jps.23992 – volume: 84 start-page: 228 year: 2013 ident: 14056_CR21 publication-title: Eur J Pharm Biopharm doi: 10.1016/j.ejpb.2012.12.018 – volume: 10 start-page: 14 year: 2019 ident: 14056_CR18 publication-title: Front Prarmacol doi: 10.3389/fphar.2019.00014 – volume: 14 start-page: 1226 year: 2022 ident: 14056_CR4 publication-title: Viruses doi: 10.3390/v14061226 – volume: 10 start-page: 73 year: 2015 ident: 14056_CR24 publication-title: Asian J Pharm Sci doi: 10.1016/j.ajps.2014.07.001 – volume: 157 start-page: 1226 year: 2017 ident: 14056_CR11 publication-title: Carbohydr Polym doi: 10.1016/j.carbpol.2016.09.094 – volume: 29 start-page: 568 year: 2008 ident: 14056_CR20 publication-title: Int J Thermophys doi: 10.1007/s10765-008-0415-z – volume: 13 start-page: 1665 year: 2021 ident: 14056_CR2 publication-title: Viruses doi: 10.3390/v13081665 – volume: 43 start-page: 151 year: 2017 ident: 14056_CR28 publication-title: Drug Dev Ind Pharm doi: 10.1080/03639045.2016.1225755 – volume: 44 start-page: 291 year: 2001 ident: 14056_CR31 publication-title: Carbohydr Polym doi: 10.1016/S0144-8617(00)00245-9 – volume: 10 start-page: 327 year: 2020 ident: 14056_CR10 publication-title: J Nanostruct – volume: 226 start-page: 832 year: 2011 ident: 14056_CR26 publication-title: Z Kristallogr doi: 10.1524/zkri.2011.1399 – volume: 226 start-page: 147 year: 2001 ident: 14056_CR23 publication-title: Int J Pharm doi: 10.1016/S0378-5173(01)00801-8 – volume: 10 start-page: 184 year: 2018 ident: 14056_CR3 publication-title: Viruses doi: 10.3390/v10040184 – volume: 397 year: 2024 ident: 14056_CR6 publication-title: J Mol Liq doi: 10.1016/j.molliq.2024.124074 – volume: 32 start-page: 840 year: 2015 ident: 14056_CR16 publication-title: Pharm Res doi: 10.1007/s11095-014-1500-6 – volume: 6 start-page: 32869 year: 2021 ident: 14056_CR25 publication-title: ACS Omega doi: 10.1021/acsomega.1c04866 – volume: 107 start-page: 16 year: 2016 ident: 14056_CR17 publication-title: Eur J Pharm Biopharm doi: 10.1016/j.ejpb.2016.06.024 – volume-title: Handbook of pharmaceutical excipients year: 2009 ident: 14056_CR9 – volume: 394 start-page: 75 year: 2010 ident: 14056_CR12 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2010.04.037 – volume: 29 start-page: 264 year: 2024 ident: 14056_CR8 publication-title: Molecules doi: 10.3390/molecules29010264 – volume: 292 year: 2022 ident: 14056_CR14 publication-title: Carbohydr Polym doi: 10.1016/j.carbpol.2022.119680 – volume: 14 start-page: 411 year: 2021 ident: 14056_CR27 publication-title: Pharmaceuticals doi: 10.3390/ph14050411 – volume: 81 start-page: 132 year: 2009 ident: 14056_CR1 publication-title: Antivir Res doi: 10.1016/j.antiviral.2008.10.009 – volume: 87 start-page: 48 year: 2016 ident: 14056_CR13 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2016.02.030 – volume: 20 start-page: 608 year: 2019 ident: 14056_CR15 publication-title: Biomacromol doi: 10.1021/acs.biomac.8b01150 – volume: 15 start-page: 226 year: 2023 ident: 14056_CR5 publication-title: Pharmaceutics doi: 10.3390/pharmaceutics15010226 – start-page: 125 volume-title: Developing solid oral dosage forms: Pharmaceutical theory and practice. Part I- Theories and techniques in the characterization of drug substances and excipients year: 2009 ident: 14056_CR7 doi: 10.1016/B978-0-444-53242-8.00006-0 – volume: 51 start-page: 383 year: 2003 ident: 14056_CR30 publication-title: Carbohydr Polym doi: 10.1016/S0144-8617(02)00259-X |
SSID | ssj0009901 |
Score | 2.4185026 |
Snippet | The broad spectrum of antiviral activity and relatively low toxicity of arbidol hydrochloride have made it an interesting subject of research. Additionally,... |
SourceID | proquest crossref |
SourceType | Aggregation Database Index Database |
StartPage | 4151 |
SubjectTerms | Bioavailability Biocompatibility Dextrin Differential scanning calorimetry Excipients Fourier transforms Incompatibility Infrared spectroscopy Miscibility Mixtures Phase diagrams Polydextrose Polymers Solubility Spectrum analysis Thermogravimetry X ray powder diffraction |
Title | Arbidol hydrochloride compatibility study with starchy excipients using DSC, FTIR, TGA-FTIR, and PXRD methods |
URI | https://www.proquest.com/docview/3227303610 |
Volume | 150 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9gAvaOMiNsbkB97aoDhxnOUxKy0DjSJBJvXNimMHuks7dam07BfxMzm-pGlgIOAljZw2bXy--nzHPt8xQq8LmSQBCSOPSQkBCjAIT_gl8wJS-lRJBYxWC5w_TtjJGf0wjaa93veNrKVVJd4Ud_fqSv7HqtAGdtUq2X-w7Pqm0ADnYF84goXh-Fc2TpdiJheX_W-11Dtf6WQ6qWxaeWWzXmtbP9Zlolca1XVf3Raz65mRtq3MVMHbL0NDYrP3Ji0ie5d6zbkRE0whULRbTd_8hsxqGnllyg64GidGLpfrXwQfbFONPy_O1cXGOkc7kbqs6jsFcPlqxXIuS6i-6I9k3bbo1H24e3rpdv1uJiyCqM3Y6kxY6mxsvUayFtSY8TcEE-sa9dY9uTHZCEWssH49aLu3zH4ZgoGRkA13DoST3usq_EY6ncR6JTvyINSMmJMcdepyTz7x8dnpKc9G0-wB2g4gIAEXsJ2Oj48nbYHnxLfBvXsAJ9ByMs2fvqNLgrocwBCbbAc9dkbEqYXXLuqp-RP0cNhsBPgUXTmY4Q7McAdm2MAMa5hhBzPcwgwbmGGA2QBrYA1wA7EBBqBgDTDsAPYMZeNRNjzx3C4dXgHUvfJCSqlfSiJ8JiNJBSuCWFGpRMFo4csjWrKcgp9QEConiRAsIaoQYZgD0YyBID9HW_PFXL1AOIdgnQqijkSiaAgvcUhoLsOQEAkjR7mH-k2v8Wtbi4W3Vbd1H3PoY276mNM9dNB0LHf_2RsO7ivWpI34-3--_BI9arF7gLaq5Uq9AvpZiUNn-R8974TK |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Arbidol+hydrochloride+compatibility+study+with+starchy+excipients+using+DSC%2C+FTIR%2C+TGA-FTIR%2C+and+PXRD+methods&rft.jtitle=Journal+of+thermal+analysis+and+calorimetry&rft.au=Rojek%2C+Barbara&rft.au=Bartyzel+Agata&rft.au=Leyk+Edyta&rft.au=Plenis+Alina&rft.date=2025-03-01&rft.pub=Springer+Nature+B.V&rft.issn=1388-6150&rft.eissn=1588-2926&rft.volume=150&rft.issue=6&rft.spage=4151&rft.epage=4164&rft_id=info:doi/10.1007%2Fs10973-025-14056-4&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-6150&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-6150&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-6150&client=summon |